| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 17.139 | 17.241 | 16.313 | 15.089 | 12.096 | 8.890 | 7.544 | 9.675 | 7.055 | 3.856 |
| Total Income - EUR | 17.139 | 17.241 | 18.146 | 15.089 | 12.096 | 9.617 | 7.544 | 9.675 | 7.055 | 3.856 |
| Total Expenses - EUR | 14.849 | 16.735 | 17.128 | 14.881 | 11.958 | 9.519 | 9.314 | 10.173 | 8.915 | 9.318 |
| Gross Profit/Loss - EUR | 2.290 | 506 | 1.017 | 208 | 138 | 98 | -1.770 | -499 | -1.859 | -5.462 |
| Net Profit/Loss - EUR | 1.776 | 75 | 473 | 57 | 17 | 7 | -1.845 | -595 | -1.928 | -5.578 |
| Employees | 7 | 8 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Pro Sana Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 937 | 927 | 1.380 | 1.354 | 1.328 | 1.303 | 746 | 374 | 187 | 39.519 |
| Current Assets | 4.207 | 2.958 | 4.312 | 1.443 | 1.168 | 1.295 | 341 | 1.084 | 11 | 1.281 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 554 | 543 | 0 | 0 | 0 | 0 | 1.278 |
| Cash | 4.207 | 2.958 | 4.312 | 889 | 625 | 1.295 | 341 | 1.084 | 11 | 4 |
| Shareholders Funds | 4.738 | 4.764 | 5.157 | 5.119 | 5.037 | 4.948 | 2.993 | 2.407 | 471 | -5.110 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 406 | 452 | 535 | 468 | 1.129 | 317 | 701 | 896 | 126 | 45.910 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Pro Sana Medica Srl